Khalafizadeh A, Hashemizadegan S, Shokri F, Bakhshinejad B, Jabbari K, Motavaf M
J Cell Mol Med. 2024; 28(7):e18197.
PMID: 38506091
PMC: 10951891.
DOI: 10.1111/jcmm.18197.
Taati H, Sangani H, Davoudi A, Safabakhsh Kouchesfahani S, Hedayati M, Tarashandeh Hemmati S
Sci Rep. 2024; 14(1):3809.
PMID: 38360831
PMC: 10869841.
DOI: 10.1038/s41598-024-54344-x.
Cheng Y, Yang X, Liang L, Xin H, Dong X, Li W
BMC Cancer. 2023; 23(1):1162.
PMID: 38031087
PMC: 10685652.
DOI: 10.1186/s12885-023-11655-y.
Shakhpazyan N, Mikhaleva L, Bedzhanyan A, Sadykhov N, Midiber K, Konyukova A
Biomedicines. 2023; 11(9).
PMID: 37760852
PMC: 10525929.
DOI: 10.3390/biomedicines11092411.
Cho W, Wong C, Li K, Fong A, Fung K, Au J
Int J Mol Sci. 2023; 24(12).
PMID: 37373169
PMC: 10298104.
DOI: 10.3390/ijms241210022.
Inhibition of Angiogenesis by MiR-524-5p through Suppression of AKT and ERK Activation by Targeting CXCR7 in Colon Cancer Cells.
Li X, Li Z, Li C, Fang Y, Zhang G, Yan Y
J Oncol. 2022; 2022:7224840.
PMID: 36405246
PMC: 9671741.
DOI: 10.1155/2022/7224840.
The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1.
Zhu Y, Wang X, Zheng L, Li D, Liu Z, Teng L
J Oncol. 2022; 2022:8130132.
PMID: 36262350
PMC: 9576420.
DOI: 10.1155/2022/8130132.
Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma.
Huang J, Jiang S, Liang L, He H, Liu Y, Cong L
Front Oncol. 2022; 12:888105.
PMID: 35646635
PMC: 9133343.
DOI: 10.3389/fonc.2022.888105.
LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
Li D, Wang R, Wu N, Yu Y
Aging (Albany NY). 2022; 14(4):1797-1811.
PMID: 35183058
PMC: 8908940.
DOI: 10.18632/aging.203903.
Whole-genome-scale identification of novel non-protein-coding RNAs controlling cell proliferation and survival through a functional forward genetics strategy.
Tonge D, Darling D, Farzaneh F, Williams G
Sci Rep. 2022; 12(1):182.
PMID: 34997014
PMC: 8741825.
DOI: 10.1038/s41598-021-03983-5.
Quantitative proteomics analysis of glioblastoma cell lines after lncRNA HULC silencing.
Ye S, Wu J, Wang Y, Hu Y, Yin T, He J
Sci Rep. 2021; 11(1):12587.
PMID: 34131250
PMC: 8206103.
DOI: 10.1038/s41598-021-92089-z.
The Emerging Landscape of Long Non-Coding RNAs in Colorectal Cancer Metastasis.
Liao Z, Nie H, Wang Y, Luo J, Zhou J, Ou C
Front Oncol. 2021; 11:641343.
PMID: 33718238
PMC: 7947863.
DOI: 10.3389/fonc.2021.641343.
c-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt/β-catenin pathway.
Liu D, Liu Y, Zheng X, Liu N
Cell Death Dis. 2021; 12(2):191.
PMID: 33602903
PMC: 7892540.
DOI: 10.1038/s41419-021-03466-5.
E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer.
Guo X, Liu L, Zhang Q, Yang W, Zhang Y
Front Oncol. 2021; 10:565449.
PMID: 33489876
PMC: 7819137.
DOI: 10.3389/fonc.2020.565449.
Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion.
Sun L, Zhou X, Jiang Q, Zhuang Y, Li D
Braz J Med Biol Res. 2021; 54(2):e10394.
PMID: 33439933
PMC: 7798139.
DOI: 10.1590/1414-431X202010394.
Long noncoding RNAs: functions and mechanisms in colon cancer.
Chen S, Shen X
Mol Cancer. 2020; 19(1):167.
PMID: 33246471
PMC: 7697375.
DOI: 10.1186/s12943-020-01287-2.
Genome-wide DNA methylation analysis by MethylRad and the transcriptome profiles reveal the potential cancer-related lncRNAs in colon cancer.
Zheng G, Zhang Y, Wang H, Ding E, Qu A, Su P
Cancer Med. 2020; 9(20):7601-7612.
PMID: 32869528
PMC: 7571838.
DOI: 10.1002/cam4.3412.
Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication.
Moeng S, Son S, Lee J, Lee H, Kim T, Choi S
Biomedicines. 2020; 8(8).
PMID: 32756339
PMC: 7459718.
DOI: 10.3390/biomedicines8080267.
Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells.
Hu Y, Ye S, Li Q, Yin T, Wu J, He J
Onco Targets Ther. 2020; 13:5927-5938.
PMID: 32606802
PMC: 7319537.
DOI: 10.2147/OTT.S252915.
Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis.
Han B, Ge Y, Cui J, Liu B
Bioengineered. 2020; 11(1):524-535.
PMID: 32352854
PMC: 7202691.
DOI: 10.1080/21655979.2020.1757224.